title: Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.
abstract: The study of cognitive function in Down syndrome (DS) has advanced rapidly in the past decade. Mouse models have generated data regarding the neurological basis for the specific cognitive profile of DS (i.e., deficits in aspects of hippocampal, prefrontal, and cerebellar function) and have uncovered pharmacological treatments with the potential to affect this phenotype. Given this progress, the field is at a juncture in which we require assessments that may effectively translate the findings acquired in mouse models to humans with DS. In this chapter, we describe the cognitive profile of humans with DS and associated mouse models, discussing the ways in which we may merge these findings so as to more fully understand cognitive strengths and weaknesses in this population. New directions for approaches to cognitive assessment in mice and humans are discussed.
authors.affiliation: University of Arizona, Down Syndrome Research Group, Tucson, AZ, USA. jamie.edgin@gmail.com
authors.forename: Jamie O
authors.initials: JO
authors.lastname: Edgin
authors.forename: Gina M
authors.initials: GM
authors.lastname: Mason
authors.forename: Goffredina
authors.initials: G
authors.lastname: Spanò
authors.forename: Andrea
authors.initials: A
authors.lastname: Fernández
authors.forename: Lynn
authors.initials: L
authors.lastname: Nadel
mesh_terms: D000818:Animals; D001921:Brain / Q000254:growth & development / Q000473:pathology; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology*; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000150:complications* / Q000235:genetics / Q000473:pathology; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009434:Neural Pathways / Q000473:pathology / Q000503:physiopathology; D010641:Phenotype